BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 8328786)

  • 1. Experimental chemotherapy with combinations of ergosterol biosynthesis inhibitors in murine models of Chagas' disease.
    Maldonado RA; Molina J; Payares G; Urbina JA
    Antimicrob Agents Chemother; 1993 Jun; 37(6):1353-9. PubMed ID: 8328786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mevinolin (lovastatin) potentiates the antiproliferative effects of ketoconazole and terbinafine against Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies.
    Urbina JA; Lazardi K; Marchan E; Visbal G; Aguirre T; Piras MM; Piras R; Maldonado RA; Payares G; de Souza W
    Antimicrob Agents Chemother; 1993 Mar; 37(3):580-91. PubMed ID: 8460926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrastructural alterations induced by two ergosterol biosynthesis inhibitors, ketoconazole and terbinafine, on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi.
    Lazardi K; Urbina JA; de Souza W
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2097-105. PubMed ID: 2073100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiproliferative effects and mechanism of action of ICI 195,739, a novel bis-triazole derivative, on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi.
    Urbina JA; Lazardi K; Aguirre T; Piras MM; Piras R
    Antimicrob Agents Chemother; 1991 Apr; 35(4):730-5. PubMed ID: 2069379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activities of the triazole derivative SCH 56592 (posaconazole) against drug-resistant strains of the protozoan parasite Trypanosoma (Schizotrypanum) cruzi in immunocompetent and immunosuppressed murine hosts.
    Molina J; Martins-Filho O; Brener Z; Romanha AJ; Loebenberg D; Urbina JA
    Antimicrob Agents Chemother; 2000 Jan; 44(1):150-5. PubMed ID: 10602737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiproliferative effects and mechanism of action of SCH 56592 against Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies.
    Urbina JA; Payares G; Contreras LM; Liendo A; Sanoja C; Molina J; Piras M; Piras R; Perez N; Wincker P; Loebenberg D
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1771-7. PubMed ID: 9661019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrastructural alterations induced by ICI 195,739, a bis-triazole derivative with strong antiproliferative action against Trypanosoma (Schizotrypanum) cruzi.
    Lazardi K; Urbina JA; de Souza W
    Antimicrob Agents Chemother; 1991 Apr; 35(4):736-40. PubMed ID: 2069380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiproliferative synergism of the allylamine SF 86-327 and ketoconazole on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi.
    Urbina JA; Lazardi K; Aguirre T; Piras MM; Piras R
    Antimicrob Agents Chemother; 1988 Aug; 32(8):1237-42. PubMed ID: 3056256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiproliferative effects of delta 24(25) sterol methyl transferase inhibitors on Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies.
    Urbina JA; Vivas J; Lazardi K; Molina J; Payares G; Piras MM; Piras R
    Chemotherapy; 1996; 42(4):294-307. PubMed ID: 8804798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations induced by the antifungal compounds ketoconazole and terbinafine in Leishmania.
    Vannier-Santos MA; Urbina JA; Martiny A; Neves A; de Souza W
    J Eukaryot Microbiol; 1995; 42(4):337-46. PubMed ID: 7620457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiparasitic activity of risedronate in a murine model of acute Chagas' disease.
    Garzoni LR; Waghabi MC; Baptista MM; de Castro SL; Meirelles Mde N; Britto CC; Docampo R; Oldfield E; Urbina JA
    Int J Antimicrob Agents; 2004 Mar; 23(3):286-90. PubMed ID: 15164970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The chemotherapy of Chagas disease].
    Stoppani AO
    Medicina (B Aires); 1999; 59 Suppl 2():147-65. PubMed ID: 10668258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cross-resistance of Candida albicans to several different families of antifungals with ergosterol biosynthesis-inhibiting activity].
    Hiratani T; Yamaguchi H
    Jpn J Antibiot; 1994 Feb; 47(2):125-8. PubMed ID: 8151906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cure of short- and long-term experimental Chagas' disease using D0870.
    Urbina JA; Payares G; Molina J; Sanoja C; Liendo A; Lazardi K; Piras MM; Piras R; Perez N; Wincker P; Ryley JF
    Science; 1996 Aug; 273(5277):969-71. PubMed ID: 8688084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of the new triazole derivative albaconazole against Trypanosoma (Schizotrypanum) cruzi in dog hosts.
    Guedes PM; Urbina JA; de Lana M; Afonso LC; Veloso VM; Tafuri WL; Machado-Coelho GL; Chiari E; Bahia MT
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4286-92. PubMed ID: 15504854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amiodarone has intrinsic anti-Trypanosoma cruzi activity and acts synergistically with posaconazole.
    Benaim G; Sanders JM; Garcia-Marchán Y; Colina C; Lira R; Caldera AR; Payares G; Sanoja C; Burgos JM; Leon-Rossell A; Concepcion JL; Schijman AG; Levin M; Oldfield E; Urbina JA
    J Med Chem; 2006 Feb; 49(3):892-9. PubMed ID: 16451055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effects of ketoconazole and SF-86327 on the proliferation of epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi.
    Urbina JA; Lazardi K; Larralde G; Aguirre T; Piras MM; Piras R
    Ann N Y Acad Sci; 1988; 544():357-8. PubMed ID: 3063176
    [No Abstract]   [Full Text] [Related]  

  • 18. Cure of experimental Chagas' disease by the bis-triazole DO870 incorporated into 'stealth' polyethyleneglycol-polylactide nanospheres.
    Molina J; Urbina J; Gref R; Brener Z; Rodrigues Júnior JM
    J Antimicrob Chemother; 2001 Jan; 47(1):101-4. PubMed ID: 11152439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitrypanosomal Treatment with Benznidazole Is Superior to Posaconazole Regimens in Mouse Models of Chagas Disease.
    Khare S; Liu X; Stinson M; Rivera I; Groessl T; Tuntland T; Yeh V; Wen B; Molteni V; Glynne R; Supek F
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6385-94. PubMed ID: 26239982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo activity of the bis-triazole D0870 against drug-susceptible and drug-resistant strains of the protozoan parasite Trypanosoma cruzi.
    Molina J; Brener Z; Romanha AJ; Urbina JA
    J Antimicrob Chemother; 2000 Jul; 46(1):137-40. PubMed ID: 10882704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.